Top

Published in:

2018 | OriginalPaper | Chapter

4. Translational Clinical Applications of Micro-/Nanoimaging Probes: Challenges and Perspectives

Authors : Senmin Wu, Hui Zhu, Jianle Huang, Kai Chen, Yan Yang, Chunpeng Zou, Zhe Liu

Published in: Advances in Functional Micro-/Nanoimaging Probes

Publisher: Springer Singapore

Activate our intelligent search to find suitable subject content or patents.

search-config

AI-assisted search

Off

Abstract

With the upgraded innovations in material science and translational medicine, micro-/nanoimaging probes show great promises for clinical translations to serve human healthcare. A number of micro-/nanoimaging probes have been approved for clinical imaging in US, CT, PET, SPECT, etc., and tremendous agents are at the status of clinical trials or under translations. This chapter focuses on the current commercially available imaging probes and their biomedical roles in disease diagnosis for patients. The potential challenges and future perspectives of imaging probes under evaluation are also briefly disclosed.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

inform now

previous chapter Biomedical Applications of Functional Micro-/Nanoimaging Probes

next chapter Outlook for Next-Generation Micro-/Nanoimaging Probes

Kurup, N., Naik, P.: Microbubbles: a novel delivery system. Asian J. Pharm. Res. Healthc. 2, 228 (2013)

Hitesh, J., Parth, P., Suraj, F., Prachi, P., Shikha, Y.: Microbubbles-a potential ultrasound tool in drug delivery. Asian J. Pharm. Clin. Res. 4, 6–11 (2011)

Patel, R.M.: Microbubble: an ultrasound contrast agent in molecular imaging. Pharma Times 40, 15–19 (2008)

Palekar-Shanbhag, P., Chogale, M.M., Jog, S.V., Gaikwad, S.S.: Microbubbles and their applications in pharmaceutical targeting. Curr. Drug Deliv. 10, 363–373 (2013)CrossRef

Ittrich, H., Peldschus, K., Raabe, N., Kaul, M., Adam, G.: Superparamagnetic iron oxide nanoparticles in biomedicine: Applications and developments in diagnostics and therapy. RoFo: Fortschritte auf dem Gebiete der Roentgenstrahlen und der Nuklearmedizin 185, 1149–1166 (2013)CrossRef

Lee, N., Choi, S.H., Hyeon, T.: Nano-sized ct contrast agents. Adv. Mater. 25, 2641–2660 (2013)CrossRef

Bean, C.P., Livingston, J.D.: Superparamagnetism. J. Appl. Phys. 30, S120–S129 (1959)CrossRef

Schoonman, J.: Nanostructured materials in solid state ionics. Solid State Ionics 135, 5–19 (2000)CrossRef

Kemsheadl, J.T., Ugelstad, J.: Magnetic separation techniques: their application to medicine. Mol. Cell. Biochem. 67, 11–18 (1985)CrossRef

10.

Hemmingsson, A., Carlsten, J., Ericsson, A., Klaveness, J., Sperber, G.O., Thuomas, K.A.: Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging. Acta Radiol. 28, 703–705 (1987)CrossRef

11.

Josephson, L., Lewis, J., Jacobs, P., Hahn, P.F., Stark, D.D.: The Effects of Iron Oxides on Proton Relaxivity. Prentice-Hall (1988)

12.

Rubin, G.D., Rofsky, N.M.: CT and MR Angiography: Comprehensive Vascular Assessment. Lippincott Williams & Wilkins (2008)

13.

Molinari, F., Fink, C., Risse, F., Tuengerthal, S., Bonomo, L., Kauczor, H.U.: Assessment of differential pulmonary blood flow using perfusion magnetic resonance imaging: comparison with radionuclide perfusion scintigraphy. Invest. Radiol. 41, 624 (2006)CrossRef

14.

Ohno, Y., Hatabu, H., Higashino, T., Takenaka, D., Watanabe, H., Nishimura, Y., Yoshimura, M., Sugimura, K.: Dynamic perfusion MRI versus perfusion scintigraphy: prediction of postoperative lung function in patients with lung cancer. Am. J. Roentgenol. 182, 73–78 (2004)CrossRef

15.

Iwasawa, T., Saito, K., Ogawa, N., Ishiwa, N., Kurihara, H.: Prediction of postoperative pulmonary function using perfusion magnetic resonance imaging of the lung. J. Magn. Reson. Imaging 15, 685–692 (2002)CrossRef

16.

Weinsaft, J.W., Klem, I., Judd, R.M.: MRI for the assessment of myocardial viability. Cardiol. Clin. 25, 505–525 (2007)CrossRef

17.

Sakuma, H.: Magnetic resonance imaging for ischemic heart disease. J. Magn. Reson. Imaging 26, 3–13 (2007)CrossRef

18.

Saslow, D., Harms, S., Leach, M.O., Morris, E., Pisano, E., Sener, S.: American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA-A Cancer J. Clin. 57, 75 (2007)CrossRef

19.

Moon, M., Cornfeld, D., Weinreb, J.: Dynamic contrast-enhanced breast MR imaging. Magn. Reson. Imaging Clin. N. Am. 17, 351–362 (2009)CrossRef

20.

Fidler, J.: MR imaging of the small bowel. Radiographics 29, 1811–1825 (2009)CrossRef

21.

Schneider, G., Reimer, P., Mamann, A., Kirchin, M.A., Morana, G., Grazioli, L.: Contrast agents in abdominal imaging: current and future directions. Topics Magn. Reson. Imaging 16, 107–124 (2005)CrossRef

22.

Hricak, H., Chen, M., Coakley, F.V., Kinkel, K., Yu, K.K., Sica, G., Bacchetti, P., Powell, C.B.: Complex adnexal masses: detection and characterization with MR imaging–multivariate analysis. Radiology 214, 39 (2000)CrossRef

23.

Whitten, C.R., Desouza, N.M.: Magnetic resonance imaging of uterine malignancies. Topics Magn. Reson. Imaging. 17, 365–377 (2006)CrossRef

24.

Manfredi, R., Gui, B., Maresca, G., Fanfani, F., Bonomo, L.: Endometrial cancer: magnetic resonance imaging. Abdom. Imaging 30, 626–636 (2005)CrossRef

25.

Sohaib, S.A., Sahdev, A., Van, T.P., Jacobs, I.J., Reznek, R.H.: Characterization of adnexal mass lesions on MR imaging. Am. J. Roentgenol. 180, 1297–1304 (2003)CrossRef

26.

Calero, M., Gutierrez, L., Salas, G., Luengo, Y., Lazaro, A., Acedo, P., Morales, M.P., Miranda, R., Villanueva, A.: Efficient and safe internalization of magnetic iron oxide nanoparticles: Two fundamental requirements for biomedical applications. Nanomed. Nanotech. Biol. Med. 10, 733–743 (2014)CrossRef

27.

Weissleder, R., Elizondo, G., Wittenberg, J., Lee, A.S., Josephson, L., Brady, T.J.: Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175, 494–498 (1990)CrossRef

28.

Seneterre, E., Weissleder, R., Jaramillo, D., Reimer, P., Lee, A.S., Brady, T.J., Wittenberg, J.: Bone marrow: ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 179, 529 (1991)CrossRef

29.

Schmitz, S.A., Winterhalter, S., Schiffler, S., Gust, R., Wagner, S., Kresse, M., Coupland, S.E., Semmler, W., Wolf, K.J.: Uspio-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 221, 237 (2001)CrossRef

30.

Schmitz, S.A., Coupland, S.E., Gust, R., Winterhalter, S., Wagner, S., Kresse, M., Semmler, W., Wolf, K.J.: Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in watanabe hereditable hyperlipidemic rabbits. Invest. Radiol. 35, 460–471 (2000)CrossRef

31.

Hahn, P.F., Stark, D.D., Weissleder, R., Elizondo, G., Saini, S., Ferrucci, J.T.: Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors. Radiology 174, 361–366 (1990)CrossRef

32.

Kent, T.A., Quast, M.J., Kaplan, B.J., Lifsey, R.S., Eisenberg, H.M.: Assessment of a superparamagnetic iron oxide (AMI-25) as a brain contrast agent. Magn. Reson. Med. 13, 434–443 (1990)CrossRef

33.

Vellinga, M.M., Oude, E., Seewann, A., Pouwels, P., Wattjes, P., van der Pol, S.M., Pering, C., Polman, C., de Vries, H., Geurts, J., Barkhof, F.: Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain 131, 800–807 (2008)CrossRef

34.

Ferrucci, J.T., Stark, D.D.: Iron oxide-enhanced mr imaging of the liver and spleen: review of the first 5 years. Am. J. Roentgenol. 155, 943–950 (1990)CrossRef

35.

Imai, Y., Murakami, T., Yoshida, S., Nishikawa, M., Ohsawa, M., Tokunaga, K., Murata, M., Shibata, K., Zushi, S., Kurokawa, M.: Superparamagnetic iron oxide–enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 32, 205–212 (2000)CrossRef

36.

Pultrum, B.B., Ej, V.D.J., van Westreenen, H.L., van Dullemen, H.M., Kappert, P., Groen, H., Sietsma, J., Oudkerk, M., Plukker, J.T., van Dam, G.M.: Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging 9, 19–28 (2009)CrossRef

37.

Nguyen, B.C., Stanford, W., Thompson, B.H., Rossi, N.P., Kernstine, K.H., Kern, J.A., Robinson, R.A., Amorosa, J.K., Mammone, J.F., Outwater, E.K.: Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma. J. Magn. Reson. Imaging 10, 468–473 (1999)CrossRef

38.

Tokuhara, T., Tanigawa, N., Matsuki, M., Nomura, E., Mabuchi, H., Lee, S.W., Tatsumi, Y., Nishimura, H., Yoshinaka, R., Kurisu, Y.: Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 11, 194–200 (2008)CrossRef

39.

Ruehm, S.G., Corot, C., Vogt, P., Kolb, S., Debatin, J.F.: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103, 415 (2001)CrossRef

40.

Kooi, M.E., Cappendijk, V.C., Cleutjens, K.B., Kessels, A.G., Kitslaar, P.J., Borgers, M., Frederik, P.M., Daemen, M.J., van Engelshoven, J.M.: Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107, 2453–2458 (2003)CrossRef

41.

Hahn, P.F., Stark, D.D., Ferrucci, J.T.: Accumulation of iron oxide particles around liver metastases during MR imaging. Gastrointest. Radiol. 17, 173–174 (1992)CrossRef

42.

Moore, A., Marecos, E., Bogdanov Jr., A., Weissleder, R.: Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214, 568–574 (2000)CrossRef

43.

Saleh, A., Schroeter, M., Jonkmanns, C., Hartung, H.P., Modder, U., Jander, S.: In vivo MRI of brain inflammation in human ischaemic stroke. Brain 127, 1670–1677 (2004)CrossRef

44.

Enochs, W.S., Harsh, G., Hochberg, F., Weissleder, R.: Improved delineation of human brain tumors on mr images using a long-circulating, superparamagnetic iron oxide agent. J. Magn. Reson. Imaging 9, 228–232 (1999)CrossRef

45.

Eniola, A.O., Willcox, P.J., Hammer, D.A.: Interplay between rolling and firm adhesion elucidated with a cell-free system engineered with two distinct receptor-ligand pairs. Biophys. J. 85, 2720–2731 (2003)CrossRef

46.

Liu, Y., Miyoshi, H., Nakamura, M.: Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. J. Control. Release 114, 89–99 (2006)CrossRef

47.

Amberg, J.R., Thompson, W.M., Golberger, L., Williamson, S., Alexander, R., Bates, M.: Factors in the intestinal absorption of oral cholecystopaques. Invest. Radiol. 15, S136 (1980)CrossRef

48.

Berk, R.N., Loeb, P.M.: Pharmacology and physiology of the biliary radiographic contrast materials. Semin. Roentgenol. 11, 147–156 (1976)CrossRef

49.

Berk, R.N., Loeb, P.M., Cobo-Frenkel, A., Barnhart, J.L.: The biliary and urinary excretion of sodium tyropanoate and sodium ipodate in dogs: Pharmacokinetics, influence of bile salts and choleretic effects with comparison to iopanoic acid. Invest. Radiol. 12, 85 (1977)CrossRef

50.

Janes, J.O., Dietschy, J.M., Berk, R.N., Loeb, P.M., Barnhart, J.L.: Determinants of the rate of intestinal absorption of oral cholecystographic contrast agents in the dog jejunum. Gastroenterology 76, 970–977 (1979)

51.

Chilton, C., Swanson, D., Chilton, H., Thrall, J.: Pharmaceuticals in Medical Imaging. Macmillan Publishing Co. (1990)

52.

Sovak, M., Hoey, G.B., Smith, K.R.: Radiocontrast agents. Handb. Exp. Pharmacol. 73, 1–125 (1984)CrossRef

53.

Dawson, P., Cosgrove, D.O., Grainger, R.G.: Textbook of Contrast Media. Isis Medical Media, Calif (1999)

54.

Siegel, R.L., Miller, K.D., Jemal, A.: Cancer statistics, 2015. CA Cancer J. Clin. 65, 5–29 (2015)CrossRef

55.

Talbot, J.N., Fartoux, L., Balogova, S., Nataf, V., Kerrou, K., Gutman, F., Huchet, V., Ancel, D., Grange, J.D., Rosmorduc, O.: Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of ¹⁸F-fluorocholine and ¹⁸F-FDG in patients with cirrhosis or chronic liver disease. J. Nucl. Med. 51, 1699–1706 (2010)CrossRef

56.

How, K.N., Dugue, A.E., Sevin, E., Allouache, N., Lesaunier, F., Joly, F., Aide, N.: Pairwise comparison of ¹⁸F-FDG and ¹⁸F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy. Nucl. Med. Commun. 37, 348–355 (2016)CrossRef

57.

Garcia, V., Jimenez, A., Villena, M., Jimenez, L., Borras, M.: ¹⁸F-fluorocholine PET/CT, brain MRI, and 5-aminolevulinic acid for the assessment of tumor resection in high-grade glioma. Clin. Nucl. Med. 42, e300–e303 (2017)CrossRef

58.

Balogova, S., Huchet, V., Kerrou, K., Nataf, V., Gutman, F., Antoine, M., Ruppert, A., Prignon, A., Lavolee, A., Montravers, F., Mayaud, C., Cadranel, J., Talbot, J.: Detection of bronchioloalveolar cancer by means of PET/CT and ¹⁸F-fluorocholine, and comparison with ¹⁸F-fluorodeoxyglucose. Nucl. Med. Commun. 31, 389–397 (2010)

59.

Are, C., Meyer, B., Stack, A., Ahmad, H., Smith, L., Qian, B., Song, T., Chowdhury, S.: Global trends in the burden of liver cancer. J. Surg. Oncol. 115, 591–602 (2017)CrossRef

60.

Kubota, R., Kubota, K., Yamada, S., Tada, M., Takahashi, T., Iwata, R., Tamahashi, N.: Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J. Nucl. Med. 36, 484–492 (1995)

61.

Buroni, F.E., Pasi, F., Persico, M.G., Lodola, L., Aprile, C., Nano, R.: Evidence of ¹⁸F-FCH uptake in human T98G glioblastoma cells. Anticancer Res. 35, 6439–6443 (2015)

62.

Bejanin, A., Schonhaut, D.R., La Joie, R., Kramer, J.H., Baker, S.L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., O’Neil, J.P., Gorno-Tempini, M.L., Miller, Z.A., Rosen, H.J., Miller, B.L., Jagust, W.J., Rabinovici, G.D.: Tau pathology and neurodegeneration contribute to cognitive impairment in alzheimer’s disease. Brain 140, 3286–3300 (2017)CrossRef

63.

Kang, J.M., Lee, S.Y., Seo, S., Jeong, H.J., Woo, S.H., Lee, H., Lee, Y.B., Yeon, B.K., Shin, D.H., Park, K.H., Kang, H., Okamura, N., Furumoto, S., Yanai, K., Villemagne, V.L., Seong, J.K., Na, D.L., Ido, T., Cho, J., Lee, K.M., Noh, Y.: Tau positron emission tomography using [(18)F]THK5351 and cerebral glucose hypometabolism in alzheimer’s disease. Neurobiol. Aging 59, 210–219 (2017)CrossRef

64.

Ueno, A., Masugi, Y., Yamazaki, K., Komuta, M., Effendi, K., Tanami, Y., Tsujikawa, H., Tanimoto, A., Okuda, S., Itano, O., Kitagawa, Y., Kuribayashi, S., Sakamoto, M.: OATP1B3 expression is strongly associated with Wnt/beta-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma. J. Hepatol. 61, 1080–1087 (2014)CrossRef

65.

Junking, M., Grainok, J., Thepmalee, C., Wongkham, S., Yenchitsomanus, P.T.: Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA. Tumour Biol. 39, 1010428317733367 (2017)CrossRef

66.

Piert, M., Montgomery, J., Kunju, L.P., Siddiqui, J., Rogers, V., Rajendiran, T., Johnson, T.D., Shao, X., Davenport, M.S.: ¹⁸F-choline PET/MRI: The additional value of pet for MRI-guided transrectal prostate biopsies. J. Nucl. Med. 57, 1065–1070 (2016)CrossRef

67.

Tardy, I., Pochon, S., Theraulaz, M., Emmel, P., Passantino, L., Tranquart, F., Schneider, M.: Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest. Radiol. 45, 573–578 (2010)CrossRef

Title: Translational Clinical Applications of Micro-/Nanoimaging Probes: Challenges and Perspectives
Authors: Senmin Wu
Hui Zhu
Jianle Huang
Kai Chen
Yan Yang
Chunpeng Zou
Zhe Liu
Publisher: Springer Singapore
Book: Advances in Functional Micro-/Nanoimaging Probes
Print ISBN: 978-981-10-4803-6

Electronic ISBN: 978-981-10-4804-3

Copyright Year: 2018
DOI: https://doi.org/10.1007/978-981-10-4804-3_4

Springer Professional

Abstract

Please log in to get access to your license.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Technik"

Premium Partners